Company Profile for Illumina, Inc.Illumina is a leading developer, manufacturer, and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function. Using proprietary technologies, Illumina provides a comprehensive line of products and services that serve the sequencing, genotyping Genotyping refers to the process of determining the genotype of an individual with a biological assay. Current methods of doing this include PCR, DNA sequencing, and hybridization to DNA microarrays or beads. , and gene expression markets. Customers include leading genomic genomic pertaining to a genome. genomic clone see clone. genomic DNA the DNA sequences making up the genome of an individual. genomic library see gene bank. research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. . Illumina's tools provide researchers around the world with the performance, throughput The speed with which a computer processes data. It is a combination of internal processing speed, peripheral speeds (I/O) and the efficiency of the operating system and other system software all working together. 1. , cost effectiveness, and flexibility necessary to perform the billions of genetic tests needed to extract To decompress. WinZip and other decompression utilities use the term to mean "pulling out" the original files from the compressed archive. See WinZip and data compression. valuable medical information from advances in genomics ge·no·mics n. The study of all of the nucleotide sequences, including structural genes, regulatory sequences, and noncoding DNA segments, in the chromosomes of an organism. and proteomics pro·te·o·mics n. The analysis of the expression, localization, functions, and interactions of the proteins produced by the genes of an organism. . This information will enable researchers to correlate genetic variation and biological function, which will enhance drug discovery and clinical research, allow diseases to be detected earlier, and permit better choices of drugs for individual patients. < < < Company: Illumina, Inc. < < < < < < Headquarters Address: 9885 Towne Centre Drive < < < San Diego, CA 92121 < < < < < < Main Telephone: 858-202-4500 < < < < < < Ticker: ILMN(NASDAQ) < < < < < < Type of Organization: Public < < < < < < Industry: Biotechnology < < < < < < Earnings Release Dates: 1st Quarter: April 24, 2007 < < < 2nd Quarter: July 24, 2007 < < < < < < Key Executives: CEO: Jay Flatley < < < CFO: Christian Henry < < < < < < Public Relations < < < Contact: Maurissa Bornstein < < < Phone: 858-332-4055 < < < Email: mbornstein@illumina.com < < < < < < Investor Relations < < < Contact: Peter Fromen < < < Phone: 858-202-4507 < < < Email: pfromen@illumina.com |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion